169 related articles for article (PubMed ID: 29377574)
41. Determining optimal ALT cut-off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection.
Kang NL; Wu LY; Zheng Q; Yu XP; Hu AR; Guo Y; Li H; Ye XY; Ruan QF; Lu ZH; Wu L; Jin W; Liu YR; Pan C; Liu SS; Zhang JM; Jiang JJ; Zeng DW
Aliment Pharmacol Ther; 2024 Mar; 59(5):692-704. PubMed ID: 38178641
[TBL] [Abstract][Full Text] [Related]
42. Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
Kovari H; Ledergerber B; Battegay M; Rauch A; Hirschel B; Foguena AK; Vernazza P; Bernasconi E; Mueller NJ; Weber R
Clin Infect Dis; 2010 Feb; 50(4):502-11. PubMed ID: 20085465
[TBL] [Abstract][Full Text] [Related]
43. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
Kim KH; Na IH; Cha JM; Cho YK; Park SY; Kim HP; Song CS; Heo J; Cho M
Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):284-92. PubMed ID: 14695695
[TBL] [Abstract][Full Text] [Related]
44. Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir.
Hadziyannis SJ; Sevastianos V; Rapti I; Vassilopoulos D; Hadziyannis E
Gastroenterology; 2012 Sep; 143(3):629-636.e1. PubMed ID: 22659218
[TBL] [Abstract][Full Text] [Related]
45. Predictors of liver histological changes and a sustained virological response to peginterferon among chronic hepatitis B e antigen-positive patients with normal or minimally elevated alanine aminotransferase levels.
Chen J; Xu CR; Xi M; Hu WW; Tang ZH; Zang GQ
J Viral Hepat; 2017 Jul; 24(7):573-579. PubMed ID: 28107601
[TBL] [Abstract][Full Text] [Related]
46. Spleen thickness can predict significant liver pathology in patients with chronic hepatitis B with persistently normal alanine aminotransferase or minimally raised alanine aminotransferase: a retrospective study.
Zhang J; Du X; Zhou Z; Lv F; Yu Y
J Int Med Res; 2019 Jan; 47(1):122-132. PubMed ID: 30213226
[TBL] [Abstract][Full Text] [Related]
47. A noninvasive model discriminating significant histological changes in treatment-naive chronic hepatitis B patients with normal ALT.
Teng J; Du Y; Visalath P; Zhou T; Du B; Zhang Q; Cai W
Virol J; 2023 Jan; 20(1):7. PubMed ID: 36631824
[TBL] [Abstract][Full Text] [Related]
48. Relevance of serum interleukin-33 and ST2 levels and the natural course of chronic hepatitis B virus infection.
Huan SL; Zhao JG; Wang ZL; Gao S; Wang K
BMC Infect Dis; 2016 May; 16():200. PubMed ID: 27180842
[TBL] [Abstract][Full Text] [Related]
49. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
Wang Y; Zhao C; Zhang L; Yu W; Shen C; Wang W; Zhen Z; Zhou J
Antiviral Res; 2014 Mar; 103():51-9. PubMed ID: 24418572
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of dithiothreitol-oxidizing capacity (DOC) as a serum biomarker for chronic hepatitis B in patients exhibiting normal alanine aminotransferase levels: a pilot study towards better monitoring of disease.
Yang L; Zhang Y; Zhang K; Liu Z; He T; Zheng X; Li L; Arnér ESJ; Zhang Z; Zhang J
EClinicalMedicine; 2021 Dec; 42():101180. PubMed ID: 34765954
[TBL] [Abstract][Full Text] [Related]
51. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
52. A noninvasive model to predict liver histology in HBeAg-positive chronic hepatitis B with alanine aminotransferase ≤ 2upper limit of normal.
Gao S; Li XY; Fan YC; Sun FK; Han LY; Li F; Ji XF; Wang K
J Gastroenterol Hepatol; 2017 Jan; 32(1):215-220. PubMed ID: 27207016
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis.
Lee MH; Kim YM; Kim SG
Int J Clin Pharmacol Ther; 2012 Nov; 50(11):778-86. PubMed ID: 22943930
[TBL] [Abstract][Full Text] [Related]
54. Early experiences from one of the first treatment programs for chronic hepatitis B in sub-Saharan Africa.
Aberra H; Desalegn H; Berhe N; Medhin G; Stene-Johansen K; Gundersen SG; Johannessen A
BMC Infect Dis; 2017 Jun; 17(1):438. PubMed ID: 28629395
[TBL] [Abstract][Full Text] [Related]
55. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.
Chen CF; Lee WC; Yang HI; Chang HC; Jen CL; Iloeje UH; Su J; Hsiao CK; Wang LY; You SL; Lu SN; Chen CJ;
Gastroenterology; 2011 Oct; 141(4):1240-8, 1248.e1-2. PubMed ID: 21703214
[TBL] [Abstract][Full Text] [Related]
56. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
Ying RS; Yang Z; Chen YY; Yang KL; Xiao YH; Wu LJ; Fan HM
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):585-8. PubMed ID: 23207151
[TBL] [Abstract][Full Text] [Related]
57. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis.
Kim MN; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Song KJ; Park YN; Han KH
Hepatology; 2015 Jun; 61(6):1851-9. PubMed ID: 25643638
[TBL] [Abstract][Full Text] [Related]
58. Development and Validation of a Novel Model to Predict Liver Histopathology in Patients with Chronic Hepatitis B.
Guo H; Zhu B; Li S; Li J; Shen Z; Zheng Y; Zhao W; Tan D; Wu J; Zhang X; Jiang Q; Qi X; Mao R; Yu X; Su Z; Zhang J
Biomed Res Int; 2019; 2019():1621627. PubMed ID: 30937309
[TBL] [Abstract][Full Text] [Related]
59. Enhanced levels of interleukin-8 are associated with hepatitis B virus infection and resistance to interferon-alpha therapy.
Yang K; Guan SH; Zhang H; Pan Y; Wu YY; Wang AH; Sun BB
Int J Mol Sci; 2014 Nov; 15(11):21286-98. PubMed ID: 25407531
[TBL] [Abstract][Full Text] [Related]
60. Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferase.
Tan Y; Ye Y; Zhou X; Chen L; Wen D
PLoS One; 2015; 10(4):e0123452. PubMed ID: 25885705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
